Nuclear mapping of nanodrug delivery systems in dynamic cellular environments

ACS Nano

Volumn 6, Issue 6, 2012, Pages 4966-4972

  Bhirde, Ashwinkumar A ^a   Kapoor, Ankur ^b   Liu, Gang ^c   Iglesias Bartolome, Ramiro ^d   Jin, Albert ^a   Zhang, Guofeng ^a   Xing, Ruijun ^a   Lee, Seulki ^a   Leapman, Richard D ^a   Gutkind, J Silvio ^d   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c XIAMEN UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

cancer; computational; doxorubicin; drug resistance; iron oxide nanoparticles; live cell imaging; nuclear mapping

Indexed keywords

CANCER; COMPUTATIONAL; DOXORUBICIN; DRUG RESISTANCE; IRON OXIDE NANOPARTICLE; LIVE-CELL IMAGING; NUCLEAR MAPPING;

ALGORITHMS; CELL MEMBRANES; CYTOLOGY; FLUORESCENCE MICROSCOPY; NANOPARTICLES;

MAPPING;

DOXORUBICIN; NANOCAPSULE;

ALGORITHM; ARTICLE; AUTOMATED PATTERN RECOGNITION; CELL NUCLEUS; EXPERIMENTAL NEOPLASM; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ALGORITHMS; CELL LINE, TUMOR; CELL NUCLEUS; DOXORUBICIN; HUMANS; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; PATTERN RECOGNITION, AUTOMATED;

EID: 84862901389     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn300516g     Document Type: Article

References (36)

1. Zahedi, P.; De Souza, R.; Piquette-Miller, M. Optimizing Cancer Care: Is the Future Bright? Clin. Pharmacol. Ther. 2011, 90, 347-350
2. Lameire, N.; Kruse, V.; Rottey, S. Nephrotoxicity of Anticancer Drugs-an Underestimated Problem? Acta. Clin. Belg. 2011, 66, 337-345
3. Nielsen, D.; Maare, C.; Skovsgaard, T. Cellular Resistance to Anthracyclines Gen. Pharmacol. 1996, 27, 251-255
4. Pachman, D. R.; Barton, D. L.; Watson, J. C.; Loprinzi, C. L. Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment Clin. Pharmacol. Ther. 2011, 90, 377-387
5. Fardell, J. E.; Vardy, J.; Johnston, I. N.; Winocur, G. Chemotherapy and Cognitive Impairment: Treatment Options Clin. Pharmacol. Ther. 2011, 90, 366-376
6. Bergman, P. J. Mechanisms of Anticancer Drug Resistance Vet. Clin. North Am. Small Anim. Pract. 2003, 33, 651-667
7. Weis, S. M.; Cheresh, D. A. Tumor Angiogenesis: Molecular Pathways and Therapeutic Targets Nat. Med. 2011, 17, 1359-1370
8. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
9. Bhirde, A. A.; Patel, S.; Sousa, A. A.; Patel, V.; Molinolo, A. A.; Ji, Y.; Leapman, R. D.; Gutkind, J. S.; Rusling, J. F. Distribution and Clearance of PEG-Single-Walled Carbon Nanotube Cancer Drug Delivery Vehicles in Mice Nanomedicine (London) 2010, 5, 1535-1546
10. Yan, Y.; Ochs, C. J.; Such, G. K.; Heath, J. K.; Nice, E. C.; Caruso, F. Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules Adv. Mater. 2010, 22, 5398-5403
11. Meng, H.; Liong, M.; Xia, T.; Li, Z.; Ji, Z.; Zink, J. I.; Nel, A. E. Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line ACS Nano 2010, 4, 4539-4550
12. Sengupta, S.; Eavarone, D.; Capila, I.; Zhao, G.; Watson, N.; Kiziltepe, T.; Sasisekharan, R. Temporal Targeting of Tumour Cells and Neovasculature with a Nanoscale Delivery System Nature 2005, 436, 568-572
13. Ma, X. W.; Zhao, Y. L.; Liang, X. J. Nanodiamond Delivery Circumvents Tumor Resistance to Doxorubicin Acta Pharmacol. Sin. 2011, 32, 543-544
14. Chow, E. K.; Zhang, X. Q.; Chen, M.; Lam, R.; Robinson, E.; Huang, H.; Schaffer, D.; Osawa, E.; Goga, A.; Ho, D. Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment Sci. Transl. Med. 2011, 3, 73ra21
15. Bhirde, A. A.; Patel, V.; Gavard, J.; Zhang, G.; Sousa, A. A.; Masedunskas, A.; Leapman, R. D.; Weigert, R.; Gutkind, J. S.; Rusling, J. F. Targeted Killing of Cancer Cells in Vivo and in Vitro with EGF-Directed Carbon Nanotube-Based Drug Delivery ACS Nano 2009, 3, 307-316
16. Koo, H.; Huh, M. S.; Sun, I. C.; Yuk, S. H.; Choi, K.; Kim, K.; Kwon, I. C. In Vivo Targeted Delivery of Nanoparticles for Theranosis Acc. Chem. Res. 2011, 44, 1018-1028
17. Willmann, J. K.; van Bruggen, N.; Dinkelborg, L. M.; Gambhir, S. S. Molecular Imaging in Drug Development Nat. Rev. Drug Discovery 2008, 7, 591-607
18. de Jongh, F. E.; van Veen, R. N.; Veltman, S. J.; de Wit, R.; van der Burg, M. E.; van den Bent, M. J.; Planting, A. S.; Graveland, W. J.; Stoter, G.; Verweij, J. Weekly High-Dose Cisplatin is a Feasible Treatment Option: Analysis on Prognostic Factors for Toxicity in 400 Patients Br. J. Cancer 2003, 88, 1199-1206
19. Fornari, F. A.; Randolph, J. K.; Yalowich, J. C.; Ritke, M. K.; Gewirtz, D. A. Interference by Doxorubicin with DNA Unwinding in MCF-7 Breast Tumor Cells Mol. Pharmacol. 1994, 45, 649-656
20. Momparler, R. L.; Karon, M.; Siegel, S. E.; Avila, F. Effect of Adriamycin on DNA, RNA, and Protein Synthesis in Cell-Free Systems and Intact Cells Cancer Res. 1976, 36, 2891-2895
21. Zeller, C.; Dai, W.; Steele, N. L.; Siddiq, A.; Walley, A. J.; Wilhelm-Benartzi, C. S.; Rizzo, S.; van der Zee, A.; Plumb, J. A.; Brown, R. Candidate DNA Methylation Drivers of Acquired Cisplatin Resistance in Ovarian Cancer Identified by Methylome and Expression Profiling. Oncogene 2012, Jan 16. doi: 10.1038/onc.2011.611.
22. Torchilin, V. P. Fluorescence Microscopy to Follow the Targeting of Liposomes and Micelles to Cells and Their Intracellular Fate Adv. Drug Delivery Rev. 2005, 57, 95-109
23. Hamilton, N. Quantification and Its Applications in Fluorescent Microscopy Imaging Traffic 2009, 10, 951-961
24. Muzzey, D.; van Oudenaarden, A. Quantitative Time-Lapse Fluorescence Microscopy in Single Cells Annu. Rev. Cell Dev. Biol. 2009, 25, 301-327
25. Mikhaylov, G.; Mikac, U.; Magaeva, A. A.; Itin, V. I.; Naiden, E. P.; Psakhye, I.; Babes, L.; Reinheckel, T.; Peters, C.; Zeiser, R.; Bogyo, M.; Turk, V.; Psakhye, S. G.; Turk, B.; Vasiljeva, O. Ferri-Liposomes as an MRI-Visible Drug-Delivery System for Targeting Tumours and Their Microenvironment Nat. Nanotechnol. 2011, 6, 594-602
26. Namiki, Y.; Namiki, T.; Yoshida, H.; Ishii, Y.; Tsubota, A.; Koido, S.; Nariai, K.; Mitsunaga, M.; Yanagisawa, S.; Kashiwagi, H.; Mabashi, Y.; Yumoto, Y.; Hoshina, S.; Fujise, K.; Tada, N. A Novel Magnetic Crystal-Lipid Nanostructure for Magnetically Guided in Vivo Gene Delivery Nat. Nanotechnol. 2009, 4, 598-606
27. Plank, C. Nanomedicine: Silence the Target Nat. Nanotechnol. 2009, 4, 544-545
28. Paoloni, M.; Khanna, C. Translation of New Cancer Treatments from Pet Dogs to Humans Nat. Rev. Cancer 2008, 8, 147-156
29. Otterson, G. A.; Villalona-Calero, M. A.; Sharma, S.; Kris, M. G.; Imondi, A.; Gerber, M.; White, D. A.; Ratain, M. J.; Schiller, J. H.; Sandler, A.; Kraut, M.; Mani, S.; Murren, J. R. Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs Clin. Cancer Res. 2007, 13, 1246-1252
30. Bhirde, A.; Guo, N.; Chen, X. Targeted Nanoprobes Reveal Early Time Point Kinetics in Vivo by Time-Resolved MRI Theranostics 2011, 1, 274-276
31. Weinstein, J. S.; Varallyay, C. G.; Dosa, E.; Gahramanov, S.; Hamilton, B.; Rooney, W. D.; Muldoon, L. L.; Neuwelt, E. A. Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review J. Cereb. Blood Flow Metab. 2010, 30, 15-35
32. Xie, J.; Jon, S. Magnetic Nanoparticle-Based Theranostics Theranostics 2012, 2, 122-124
33. Quan, Q.; Xie, J.; Gao, H.; Yang, M.; Zhang, F.; Liu, G.; Lin, X.; Wang, A.; Eden, H. S.; Lee, S.; Zhang, G.; Chen, X. HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy Mol. Pharm. 2011, 8, 1669-1676
34. Brule, S.; Levy, M.; Wilhelm, C.; Letourneur, D.; Gazeau, F.; Menager, C.; Le Visage, C. Doxorubicin Release Triggered by Alginate Embedded Magnetic Nanoheaters: a Combined Therapy Adv. Mater. 2011, 23, 787-790
35. Kievit, F. M.; Wang, F. Y.; Fang, C.; Mok, H.; Wang, K.; Silber, J. R.; Ellenbogen, R. G.; Zhang, M. Doxorubicin Loaded Iron Oxide Nanoparticles Overcome Multidrug Resistance in Cancer in Vitro J. Controlled Release 2011, 152, 76-83
36. Duwez, A. S.; Cuenot, S.; Jerome, C.; Gabriel, S.; Jerome, R.; Rapino, S.; Zerbetto, F. Mechanochemistry: Targeted Delivery of Single Molecules Nat. Nanotechnol. 2006, 1, 122-125